Physician

John Thomas Ruxer, DO

According to 2025 Medicare claims, John Ruxer, DO (NPI: 1205078987) practices pain management in the Paducah, KY-IL market, with the plurality of this provider's patient population coming from Mc Cracken, KY. This provider's primary affiliated billing organization is SOUTHERN PAIN AND REHABILITATION INC (NPI: 1295377497; TIN: 842870727) and primary practice location at 42001-9647. Ruxer is affiliated with the IRCCO (ACO ID: A2619) and The Rural Advantage LLC (ACO ID: A5257), participating under the MSSP model.

Ruxer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,359 traditional Medicare patients, billed 15,767 HCPCS/CPT codes, and received $1,155,436 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,035 prescription claims across 995 beneficiaries totaling $370,738 in drug costs, led by Belbuca (Buprenorphine Hcl). DME data shows 147 claims. Open Payments data shows 49 records totaling $3,025. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $289,318 to $370,738. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $733 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$702K$1.4M2015 Medicare payment: $856,921 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,211,130 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,403,190 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,232,139 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,355,975 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $908,338 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $870,337 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $929,798 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,036,215 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,155,436 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,12212,834$856,921
20161,58918,209$1,211,130
20171,66418,489$1,403,190
20181,44016,691$1,232,139
20191,72016,213$1,355,975
20201,54110,352$908,338
20211,1018,883$870,337
20221,27613,111$929,798
20231,24812,811$1,036,215
20241,35915,767$1,155,436

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$685K$1.4M2015 Drug cost: $289,318 (USD; Tot_Drug_Cst)2016 Drug cost: $688,819 (USD; Tot_Drug_Cst)2017 Drug cost: $1,068,189 (USD; Tot_Drug_Cst)2018 Drug cost: $1,293,681 (USD; Tot_Drug_Cst)2019 Drug cost: $1,370,466 (USD; Tot_Drug_Cst)2020 Drug cost: $837,770 (USD; Tot_Drug_Cst)2021 Drug cost: $561,455 (USD; Tot_Drug_Cst)2022 Drug cost: $487,657 (USD; Tot_Drug_Cst)2023 Drug cost: $465,452 (USD; Tot_Drug_Cst)2024 Drug cost: $370,738 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157054,548$289,318
20161,1388,620$688,819
20171,48514,987$1,068,189
20181,48416,032$1,293,681
20191,90118,515$1,370,466
20201,89014,340$837,770
20211,2388,121$561,455
20221,1036,839$487,657
20239975,673$465,452
20249956,035$370,738

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$94K$188K2016 Medicare payment: $27,390 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $11,222 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $578 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $70,886 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $66,397 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $188,373 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $120,026 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
20162727$27,390
20171111$11,222
2018N/RN/RN/R
2019N/R11$578
2020N/RN/RN/R
20217777$70,886
20227575$66,397
2023212212$188,373
2024147147$120,026

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,0092,798$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7281,317$60
80307Testing for presence of drug, by chemistry analyzers4851,222$60
99490Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month6923,637$45
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg468947$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BelbucaBuprenorphine Hcl1584,710$120,536
Xtampza ErOxycodone Myristate1043,019$62,167
BuprenorphineBuprenorphine1654,624$52,804
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen2,44172,024$47,180
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,51244,787$27,372

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L0651Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelfN147147$120,026

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.49$3,025Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Thomas Ruxer, DO?

Tedicare shows public-source Medicare data for John Thomas Ruxer, DO (NPI 1205078987), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Thomas Ruxer, DO have ACO affiliation data?

John Thomas Ruxer, DO is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and The Rural Advantage LLC (MSSP, ACO ID A5257).

What billing organization is linked to John Thomas Ruxer, DO?

John Thomas Ruxer, DO is linked to SOUTHERN PAIN AND REHABILITATION INC (billing NPI 1295377497) in the available physician profile data.

Does John Thomas Ruxer, DO have Open Payments data?

John Thomas Ruxer, DO has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.